[HTML][HTML] Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

CA German, SJ Baum, KC Ferdinand, M Gulati… - American Journal of …, 2022 - Elsevier
Remarkable transformations in science and healthcare have resulted in declines in mortality
from cardiovascular disease over the past several decades, largely driven by progress in …

Selected potential pharmaceutical and medical benefits of phenolic compounds: Recent advances

M Abd Elgadir, S Chigurupati, AA Mariod - Functional Food Science-Online …, 2023 - ffhdj.com
Objective: Phenolic compounds are essential for defense reactions, including antioxidant,
anti-inflammatory, antidiabetic, anti-proliferative activity, and anti-aging activity. Coming from …

[HTML][HTML] World Heart Federation roadmap for secondary prevention of cardiovascular disease: 2023 update

L Laranjo, F Lanas, MC Sun, DA Chen, L Hynes… - Global …, 2024 - ncbi.nlm.nih.gov
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

[HTML][HTML] Obesity and hypertension: obesity medicine association (OMA) clinical practice statement (CPS) 2023

TL Clayton, A Fitch, HE Bays - Obesity Pillars, 2023 - Elsevier
Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) provides an overview of the mechanisms and treatment of obesity and hypertension …

[HTML][HTML] Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis

L Mao, R Yin, L Yang, D Zhao - Frontiers in Endocrinology, 2022 - frontiersin.org
Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular
diseases. The progression of AS is a multi-step process leading to high morbidity and …

[HTML][HTML] New insights into cardiovascular diseases treatment based on molecular targets

A Wojtasińska, J Kućmierz, J Tokarek, J Dybiec… - International Journal of …, 2023 - mdpi.com
Cardiovascular diseases (CVDs) which consist of ischemic heart disease, stroke, heart
failure, peripheral arterial disease, and several other cardiac and vascular conditions are …

[HTML][HTML] Obesity Pillars Roundtable: Body mass index and body composition in Black and Female individuals. Race-relevant or racist? Sex-relevant or sexist?

HE Bays, S Gonsahn-Bollie, C Younglove, S Wharton - Obesity Pillars, 2022 - Elsevier
Background Body mass index (BMI or weight in kilograms/height in meters 2) is the most
common metric to diagnose overweight and obesity. However, a body composition analysis …

[HTML][HTML] Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?

E Domingo, P Marques, V Francisco, L Piqueras… - Pharmacological …, 2024 - Elsevier
Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide.
While many factors can contribute to CVD, atherosclerosis is the cardinal underlying …

Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives

SU Thorsen, KF Moseholm… - Current Opinion in …, 2024 - journals.lww.com
Circulating cell-free DNA and its association with cardiovas... : Current Opinion in Lipidology
Circulating cell-free DNA and its association with cardiovascular disease: what we know and …

[HTML][HTML] Protection by-biotics against hypertension programmed by maternal high fructose diet: rectification of dysregulated expression of short-chain fatty acid …

YM Chao, YL Tain, WC Lee, KLH Wu, HR Yu… - Nutrients, 2022 - mdpi.com
The role of short-chain fatty acids (SCFAs) in the brain on the developmental programming
of hypertension is poorly understood. The present study explored dysregulated tissue levels …